Free Trial

Lakeshore Biopharma (LSB) SEC Filings & 10K Form

Lakeshore Biopharma logo
$0.99 0.00 (-0.01%)
As of 03:56 PM Eastern

Recent Lakeshore Biopharma SEC Filings

DateFilerForm TypeView
05/12/2025
5:50 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2025
5:45 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2025
5:30 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2025
8:22 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form S-8 POS
03/12/2025
8:19 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
8:28 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
3:10 PM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
7:15 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:01 PM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
8:16 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
7:40 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
7:59 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
6:15 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2024
3:00 PM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K/A
09/10/2024
7:15 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:10 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
7:40 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:28 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
6:15 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form NT 20-F
07/05/2024
6:15 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:30 AM
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LSB) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners